CHU de Brest
Brest, 29609, France
NCT Number: NCT03069560
Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Brest, 29609, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SMS contact from the caregiver with patient after discharge in intervention group
Time frame: 6 months
The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.
Time frame: 6 months
A questionnaire will be provided to the caregiver to measure the feasibility of such a device
Time frame: 6 months
Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device
Time frame: 6 months
A qualitative analysis of the messages addressed to the patients during the study will be carried out.
University Hospital, Brest
Other
Acronym: C-SIAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282225
Behavior, Behavioral Symptoms
Ann Arbor, Michigan, United States
View Trial DetailsNCT05397353
Behavior, Behavioral Symptoms
Piscataway, New Jersey, United States
View Trial DetailsNCT06406972
Behavior, Behavioral Symptoms
Lund, Skåne County, Sweden
View Trial DetailsNCT03894462
Behavior, Behavioral Symptoms
Rochester, New York, United States
View Trial Details